Shares of Bionano Genomics (BNGO) rose by a staggering 50.1% in 30 days from $5.09 to $7.64 at 20:54 EST on Thursday, after two consecutive sessions in a row of losses. NASDAQ Composite (BNGO) is rising 0.78% to $14,020.33, following the last session’s upward trend,
Bionano Genomics’s last close was $7.77, 50.48% under its 52-week high of $15.69.
Today’s last reported volume for Bionano Genomics is 20369543 which is 16.3% below its average volume of 24335434.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 200.3% for the ongoing quarter and 97.2% for the next. The company’s growth estimates for the present quarter and the next is 55.6% and 50%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s last week, last month’s, and last quarter’s current volatility was a negative 0.17%, a positive 0.95%, and a positive 5.59%, respectively.
Bionano Genomics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.23% (last week), 5.05% (last month), and 5.59% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Bionano Genomics’s stock is considered to be oversold (<=20).
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $7.64 at 20:54 EST, way below its 52-week high of $15.69 and way above its 52-week low of $0.43.
Bionano Genomics’s Moving Average
Bionano Genomics’s value is way above its 50-day moving average of $6.10 and way above its 200-day moving average of $6.58.
More news about Bionano Genomics (BNGO).